1. Home
  2. Labeler Index
  3. Napo Pharmaceuticals, Inc.
  4. 70564-802
  5. Product Images: Mytesi

Product Images Mytesi

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Mytesi NDC 70564-802 by Napo Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The following chemical structure for MYTESI (crofelemer) is delayed-release tablets is an anti-diarrheal, enteric-coated drug product for oral administration. It contains 125 mg of crofelemer, a botanical drug substance that is derived from the red latex of Croton lechleri Müll. Arg. Crofelemer is an oligomeric proanthocyanidin mixture primarily composed of (+)–catechin, (–)–epicatechin, (+)–gallocatechin, and (–)–epigallocatechin monomer units linked in random sequence, as represented below. The average degree of polymerization for the oligomers ranges between 5 and 7.5, as determined by phloroglucinol degradation. - mytesi 01

The following chemical structure for MYTESI (crofelemer) is delayed-release tablets is an anti-diarrheal, enteric-coated drug product for oral administration. It contains 125 mg of crofelemer, a botanical drug substance that is derived from the red latex of Croton lechleri Müll. Arg. Crofelemer is an oligomeric proanthocyanidin mixture primarily composed of (+)–catechin, (–)–epicatechin, (+)–gallocatechin, and (–)–epigallocatechin monomer units linked in random sequence, as represented below. The average degree of polymerization for the oligomers ranges between 5 and 7.5, as determined by phloroglucinol degradation. - mytesi 01

PRINCIPAL DISPLAY PANELNDC 70564-802-60 Mytesi (crofelemer) delayed-release tablets 125 mg Swallow tablet whole. Do not crush or chew. 60 enteric coated tablets Rx only - mytesi 03

PRINCIPAL DISPLAY PANELNDC 70564-802-60 Mytesi (crofelemer) delayed-release tablets 125 mg Swallow tablet whole. Do not crush or chew. 60 enteric coated tablets Rx only - mytesi 03

Each tablet contains 125 mg of an oral (crofelemer) antidiarrheal drug, sold under the name "Storeal." The tablets should be stored between 20°C to 25°C (68°F to 77°F). The recommended dosage is one tablet per day. The drug is manufactured by Petesi, and the NDC number is 70564-802-60. The tablet must be swallowed whole and should not be chewed or crushed. Further dosage and administration information is unavailable.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.